Filing metadata

Accession number
0001209191-20-031293
Form type
Form 4
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
May 21, 2020
Reporting period
May 19, 2020
Description
Insider transaction

Explore SEC Filings Hub